Thetford Mines, Quebec – May 11, 2021 – KDA Group Inc. (TSXV: KDA) (“KDA” or the “Corporation”) is pleased to announce that its wholly owned subsidiary, Groupe Technologique Inc. (“KDA Techno”) has completed the acquisition of the ownership rights in the ZRx Prescriber to develop, commercialize and exploit the ZRx Prescriber in the United States, Europe and the United Kingdom, in consideration for 20,000,000 Class A shares (the “KDA Shares”) of KDA’s share capital (the “Transaction”).